The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Gilead Sciences
Approval Status: Approved March 1999
Treatment for: Infectious Diseases
General Information
Vistide (cidofovir injection) 75 mg/mL has been approved for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.